Newer approaches are being explored for how they engage multiple systems at once, and the early insights are worth paying attention to
Its low side-effect profile is also reassuring, making it attractive to those looking for alternative healing options
It may help with conditions like KC, TED, DED, ocular surface problems, cataracts, glaucoma, retinoblastoma, and other retinal diseases
It may also be appealing for those navigating the financial barriers of traditional GLP-1 therapy
Headaches and mild nausea are common during transitions
Assembly of the L-Carnitine Biosynthetic Pathway After efficient enzymes for the last and penultimate step of the L-carnitine biosynthetic pathway had been identified, enzymes for the first two steps were selected: TML hydroxylase and an HTML aldolase (Supplementary Table 1)